Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital

References

• Peters KM, Killinger KA, Ibrahim IA, et al. The relationship Between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency. Neurourol Urodyn. 2008;27(8):775–778.
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116–126.
   PubMed Web of Science ®Google Scholar
• Milsom I, Kaplan SA, Coyne KS, et al. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90–96.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–360.
   PubMed Web of Science ®Google Scholar
• Gajewski JB, Schurch B, Hamid R, et al. An international continence society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37(3):1152–1161.
   PubMed Web of Science ®Google Scholar
• Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther. 2006;28(4):445–460.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson’s disease. Parkinsons Dis. 2011;2011:924605.
   PubMed Web of Science ®Google Scholar
• Drake MJ. Management and rehabilitation of neurologic patients with lower urinary tract dysfunction. Handb Clin Neurol. 2015;130:451–468.
   PubMedGoogle Scholar
• Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology. 1982;20(6):614–619.
   PubMed Web of Science ®Google Scholar
• van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029–2034.
   PubMed Web of Science ®Google Scholar
• Siegel S, Noblett K, Mangel J, et al. Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated With sacral neuromodulation. Urology. 2016;94:57–63.
   PubMed Web of Science ®Google Scholar
• Paquette IM, Varma MG, Kaiser AM, et al. The American society of Colon and rectal surgeons’ clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015;58(7):623–636.
   PubMed Web of Science ®Google Scholar
• van Ophoven A, Engelberg S, Lilley H, et al. Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (nLUTD): over 20 years’ experience and future directions. Adv Ther. 2021;38(4):1987–2006.
   PubMed Web of Science ®Google Scholar
• Goldman HB, Lloyd JC, Noblett KL, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1821–1822.
   PubMedGoogle Scholar
• Matzel KE, Chartier-Kastler E, Knowles CH, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20(8):816–824.
   PubMed Web of Science ®Google Scholar
• European Association of Urology. Non-neurogenic female LUTS. n.d. [cited 2021 Dec 8]. Available from: https://uroweb.org/guideline/non-neurogenic-female-luts/#4
   Google Scholar
• Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455.
   Google Scholar
• De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6(5):823–825.
   PubMedGoogle Scholar
• Lehur PA, Sorensen M, Dudding TC, et al. Programming algorithms for sacral neuromodulation: clinical practice and evidence-recommendations for day-to-day practice. Neuromodulation. 2020;23(8):1121–1129.
   PubMed Web of Science ®Google Scholar
• Tutolo M, Ammirati E, Heesakkers J, et al. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol. 2018;73(3):406–418.
   PubMed Web of Science ®Google Scholar
• HASSOUNA MM, SIEGEL SW, LYCKLAMA ÀNŸEHOLT AAB, et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol. 2000;163(6):1849–1854.
   PubMed Web of Science ®Google Scholar
• McLeod LD, Coon CD, Martin SA, et al. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11(2):163–169.
   PubMed Web of Science ®Google Scholar
• Morgan TN, Pace N, Mohapatra A, et al. Sacral neuromodulation: Determining predictors of success. Urology. 2021;153:124–128.
   PubMed Web of Science ®Google Scholar
• Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, et al. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164(5):1476–1480.
   PubMed Web of Science ®Google Scholar
• Drossaerts J, Rademakers K, van Koeveringe G, et al. The value of urodynamic tools to guide patient selection in sacral neuromodulation. World J Urol. 2015;33(11):1889–1895.
   PubMed Web of Science ®Google Scholar
• Berghmans B, Nieman F, Leue C, et al. Prevalence and triage of first-contact complaints on pelvic floor dysfunctions in female patients at a Pelvic Care Centre. Neurourol Urodyn. 2016;35(4):503–508.
   PubMed Web of Science ®Google Scholar
• Berghmans B, Nieman F, Leue C, et al. Prevalence and triage of first contact pelvic floor dysfunction complaints in male patients referred to a Pelvic Care Centre. Neurourol Urodyn. 2016;35(4):487–491.
   PubMed Web of Science ®Google Scholar
• Mahran A, Baaklini G, Hassani D, et al. Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature. Int Urogynecol J. 2019;30(7):1023–1035.
   PubMed Web of Science ®Google Scholar
• Hijaz A, Vasavada SP, Daneshgari F, et al. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology. 2006;68(3):533–537.
   PubMed Web of Science ®Google Scholar
• Guralnick ML, Benouni S, O'Connor RC, et al. Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. Urology. 2007;69(6):1073–1076.
   PubMed Web of Science ®Google Scholar